Bibliographic Details
| Title: |
Pembrolizumab plus Lenvatinib for Synchronous Triple Primary Malignancies of the Kidney, Bladder, and Liver: Clinical Implications of Conflict of Drug Doses and Dominant Tumor Biology. |
| Authors: |
Atagi Y; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan., Fukatani Y; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan., Kouno R; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan., Seto K; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan., Hashine K; National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan. |
| Source: |
Case reports in oncology [Case Rep Oncol] 2026 Mar 31; Vol. 19 (1), pp. 805-814. Date of Electronic Publication: 2026 Mar 31 (Print Publication: 2026). |
| Publication Type: |
Case Reports; Journal Article |
| Journal Info: |
Publisher: Karger Country of Publication: Switzerland NLM ID: 101517601 Publication Model: eCollection Cited Medium: Print ISSN: 1662-6575 (Print) Linking ISSN: 16626575 NLM ISO Abbreviation: Case Rep Oncol Subsets: PubMed not MEDLINE |
| Database: |
MEDLINE Ultimate |
